Skip to content

Trafalgar International, Inc.

TRFA· OTCxbrl foundCIK 1695473

Pharmaceutical preparations552 peers

Filings
145
Raw facts
5,432
Metric values
1,300
$12.63K
FY 2021−73.7% FY21 yoy
$611.38K
Q2 2026N/M FY25 yoy
-$11.56K
Q2 2026N/M FY25 yoy
—
—
—
$0.61
Q2 2026
$111.00
Q2 2026−38.2% FY23 yoy

Financials

Revenue

$12.63KFY 2021
$95.38K0FY 2017FY 2018FY 2019FY 2020FY 2021
PeriodEndedValueKindSource trail
FY 20212021-12-31$12,630reported
FY 20202020-12-31$48,044reported
FY 20192019-12-31$7,120 revisedreported
FY 20182018-12-31$95,375reported
FY 20172017-12-31$209reported

Segments

Products
Revenue by Products, FY2019 to FY2021FY2019Product · FY2019 · $4.50KConsulting Fees · FY2019 · $2.62KFY2020Product · FY2020 · $48.04KFY2021Product · FY2021 · $12.63K
LineFY2021ShareChange
Product$12.63K100%−73.7%
Consulting Fees———
Total$12.63K

From the 10-K filed Apr 13, 2023TRFA

Pharmaceutical preparations

Trafalgar International, Inc. is the 496th largest of the 553 covered companies the SEC files under this code, by total assets. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in total assets first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Trafalgar International, Inc. · CIK 1695473 · Engraved from SEC EDGAR